Dr Anji Miller

Board Director, AUTM

Anji is a TT professional with more than 18 years’ experience of working with early-stage translational research. Anji has extensive experience of IP and contract management, licensing, business development of healthcare technologies, and development of knowledge transfer policies. Anji is Board Director at AUTM and a member of the BioIndustry Association (BIA) Cell & Gene Therapy Advisory Committee. Anji Is also the Skills Lead for Innovation Hubs for Gene Therapy funded by LifeArc and the Medical Research Charity.